Healthcare product’s research and services group

The global pharmaceutical outlook is undergoing a massive rebuild and are increasingly outsourcing research activities to academic and private contract research organizations (CROs) as a strategy to stay competitive and flexible in a world of exponentially growing knowledge, increasingly sophisticated technologies and an unstable economic environment. The drying research pipeline of APIs, changing life style and demand of user-conscious/easy to use products are further pushing the industry hard to re-imagine and reformulate products.

The “Healthcare product’s research and services group” has come forward with an idea to offer its services in the same line to global customers. Fortunately we (Jamia Hamdard University) have departments/experts of almost all areas which an industry looks for. Maintaining the highest level of integrity, reliability and ethical practices, the team works as a single point of contact between industries and the university. Our service spans in silico studies, impurity and small peptide synthesis, crystal engineering, product development, toxicological studies, HEOR and regulatory support. We offer high-quality data and a rapid turnaround period to support product development at lab scale. For particular categories of products we also offer support in technology transfer and scale-up.